China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Sees Significant Growth in Short Interest

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) was the recipient of a significant growth in short interest during the month of December. As of December 31st, there was short interest totalling 377,600 shares, a growth of 44.1% from the December 15th total of 262,000 shares. Approximately 11.0% of the company’s stock are short sold. Based on an average daily trading volume, of 1,060,000 shares, the days-to-cover ratio is currently 0.4 days.

China SXT Pharmaceuticals Trading Up 1.2 %

Shares of NASDAQ:SXTC traded up $0.01 during midday trading on Friday, hitting $0.42. 9,310 shares of the company’s stock were exchanged, compared to its average volume of 740,601. China SXT Pharmaceuticals has a 12 month low of $0.30 and a 12 month high of $3.37. The stock has a 50 day moving average price of $0.42 and a 200-day moving average price of $0.68.

About China SXT Pharmaceuticals

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.